Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
172 participants
OBSERVATIONAL
2020-06-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19
NCT06968156
Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study
NCT05074706
Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH
NCT04347460
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
NCT00246857
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Correlation of the degree of lymphopenia with the status of the patients will be done. Also correlation will be done about the relation of recovery of lymphopenia and status of the patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asymptomatic or mild symptoms patients patients
Patients with no or mild symptoms and need no respiratory support.
Complete blood picture, bone marrow aspiration cytology
none except the regular routine investigations in such cases
Severe symptoms patients
Patients who need admission to ICU because he needs oxygen by nasal canula and needs drugs whether azthromycin or remdesivir according to treatment protocol.
Complete blood picture, bone marrow aspiration cytology
none except the regular routine investigations in such cases
Critically ill patients
Patients who need artificial ventilation because of many causes and may need plasma from convalescent patients
Complete blood picture, bone marrow aspiration cytology
none except the regular routine investigations in such cases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complete blood picture, bone marrow aspiration cytology
none except the regular routine investigations in such cases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr Medhat Khafagy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Medhat Khafagy
professor of surgical oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201920008.2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.